Mono Pharmacare Limited IPO
i. Mono Pharmacare is engaged in the business of marketing of pharmaceutical products and also, they are distributors of various pharmaceutical companies. They work with various contract manufacturers who manufacture pharmaceutical products on the behalf based on compositions given by them and subsequently they sell those products under their brand “DLS Export”.
ii. They are also distributors to various pharmaceutical companies. As on February 28, 2023, the company is dealing with (distributors and stockists) 168 pharmaceutical companies and also, they are connected with 3,036 Customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
iii. Acquisition of DLS Export by way of a deed of business transfer agreement dated December 15, 2022. DLS Export, a proprietorship firm, was established by the promoter Panilam Lakhatariya on March 02, 2020. The acquisition was for an aggregate consideration of ₹ 609 lakhs, in order to grow their product portfolio in selected therapeutic areas.
Brief details of business segments
- Marketing of Pharmaceutical Products
They outsource the manufacturing of certain of their products, and currently use approximately 19 third party manufacturers. They provide compositions to manufacture each pharmaceutical product according to its specifications. Once the raw materials are sourced, their contract manufacturers begin the manufacturing according to the requirements and order given to them by the company. They manufacture products in batches within the given time frame. After the order is completed, the manufacturers provide the finished product with a quality certificate that the products are in compliance with quality standards as required by the regulatory authorities.
- Distributor of Pharmaceutical Products
The pharmaceutical industry requires a complex and efficient distribution model to ensure that patients have access to the medications they need. Pharmaceutical distribution is the process of delivering medications from the manufacturer to the healthcare provider or patient. The pharma distribution model involves several key players, including manufacturers, wholesalers, distributors, pharmacies, hospitals, and other healthcare providers. Each player in the distribution chain has a specific role to play in ensuring that medications are delivered safely and efficiently. Distributors are responsible for supplying the medications from the wholesalers to the pharmacy or healthcare provider. They also handle the storage and handling of the medications to ensure that they remain safe and effective.
- Experienced promoters and management team with industry knowledge and an established track record
- Asset-light business model and competitive products
- Scalable Business Model
Objects of the Mono Pharmacare Limited IPO:
Mono Pharmacare Limited IPO Details:
|Open Date:||Aug 28 2023|
|Close Date:||Aug 30 2023|
|Face Value:||₹ 10 Per Equity Share|
|Issue Size:||₹14.84 Cr.|
|Lot Size:||4000 Shares|
|Issue Price:||₹ 26-28 Per Equity Share|
|Listing At:||NSE Emerge|
|Listing Date:||Sep 07 2023|
Promoters And Management:
Financials of Mono Pharmacare Limited IPO:
Pariculares ( In Lakhs )
|Revenue from Operations||2,827||3,698||5,848|
|Purchase of Traded Goods||2,774||3,526||8,131|
|Change in Inventories||-118.7||-57.3||-2,797.2|
|Employee Benefits Expense||53.9||62||110|
|Depreciation & Amortisation||12.8||10.8||10.4|
Comparison With Peers:
|Name of the Company||Revenue (In Crore)||PAT (In Crore)||EPS ( in Rs)||P/E||CMP||Mcap (In Crore)|
|Mono Pharmacare Limited||58||1||0.69||40.1||28||49|
|Chandra Bhagat Pharma Limited||120||1||1.21||110.0||133||100|